Drug delivery solutions
We are committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.
Explore by platform
We are a world leader of pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. Explore our drug delivery platforms to learn more. We have a vast product offering available across each of our drug delivery platforms for human and veterinary applications, including Small Molecule Delivery, Protein Delivery, Nucleic Acid Delivery, Adjuvant Systems and Consumer Health.
Explore by product
We offer an extensive product offering to meet the needs for our customers. With an ever increasing list of high purity specialty ingredients, we are proud to be your partner in bringing drug products to market. Alongside our product range, we have extensive expertise in working with our products in their various applications, and actively work with customers to solve any issues they are facing, whether it be stabilising a difficult drug, delivering the drug to its intended site of action, or prolonging drug product shelf life through the use of high purity ingredients.
Explore by market
Our purpose, Smart science to improve lives™, is at the core of our human and veterinary market strategy. We support the pharmaceutical market by developing high purity excipients which enhance delivery, efficacy, and stability of actives. We also manufacture industry leading high purity vaccine adjuvants and innovative lipids.
Explore new products
Explore our newest range of products available across our technology platforms.
How we empower biologics delivery
Explore recent blogs:
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A3F1E1F41A1C690A537D793D09D9F2EA)
QbD Formulation Development
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A303EDE921EF0283547DD585579EDC71)
Targeted lipid nanoparticles in Nucleic Acid Delivery
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Croda joins CGT Catapult consortium to improve AAV formulation
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...